Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Design by Avery Nelson. Buy this photo. In a recent University of Michigan study, researchers ...

Immune thrombocytopenia (ITP) is an autoimmune disorder characterised by both antibody-mediated platelet destruction and impaired megakaryocyte function. This results in decreased platelet counts and ...

White pills alongside a stethoscope. Researchers sought to determine whether corticosteroids would be an effective treatment for patients with chemotherapy-induced thrombocytopenia. According to the ...

(RTTNews) - Sanofi (SNY), Friday announced that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has recommended the approval of Wayrilz for the treatment of ...

The European Medicines Agency (EMA) has recommended granting marketing authorization for rilzabrutinib (Wayrilz, Sanofi) to treat immune thrombocytopenia (ITP) in adults who are refractory to other ...

— NDA is supported by data from successful Phase III ESLIM-01 trial in patients with adult primary immune thrombocytopenia who have received at least one previous therapy — The NMPA granted ...

By David Bautz, PhD NASDAQ:CVKD READ THE FULL CVKD RESEARCH REPORT Business Update Acquires 12-LOX Inhibitor VLX-1005 for the Treatment of HIT In December 2025, Cadrenal Therapeutics, Inc.

JW Pharmaceutical announced on the 26th that clinical results and real-world prescription experiences of fostamatinib (product name Tavlesse), a treatment component for immune thrombocytopenia (ITP), ...

The FDA also approved Doptelet Sprinkle oral granules for use in children aged 1 to less than 6 years. The Food and Drug Administration (FDA) has approved Doptelet ® (avatrombopag) for the treatment ...

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Europe Thrombocytopenia Market and Competitive Landscape Highlights - 2016" report to their offering. The research ...